|
1
|
Schiff D and Purow B: Neuro-oncology: Five
new things. Neurol Clin Pract. 3:326–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: a clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yabroff KR, Harlan L, Zeruto C, Abrams J
and Mann B: Patterns of care and survival for patients with
glioblastoma multiforme diagnosed during 2006. Neuro Oncol.
14:351–359. PubMed/NCBI
|
|
4
|
Hayashi Y, Nakada M, Kinoshita M and
Hamada J: Surgical strategies for nonenhancing slow-growing gliomas
with special reference to functional reorganization: review with
own experience. Neurol Med Chir (Tokyo). 53:438–446. 2013.
View Article : Google Scholar
|
|
5
|
Aboody KS, Brown A, Rainov NG, Bower KA,
Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao D, Najbauer J, Annala AJ, Garcia E,
Metz MZ, Gutova M, Polewski MD, Gilchrist M, Glackin CA, Kim SU and
Aboody KS: Human neural stem cell tropism to metastatic breast
cancer. Stem Cells. 30:314–325. 2012. View
Article : Google Scholar
|
|
7
|
Gutova M, Shackleford GM, Khankaldyyan V,
Herrmann KA, Shi XH, Mittelholtz K, Abramyants Y, Blanchard MS, Kim
SU, Annala AJ, et al: Neural stem cell-mediated CE/CPT-11
enzyme/prodrug therapy in transgenic mouse model of intracerebellar
medulloblastoma. Gene Ther. 20:143–150. 2013. View Article : Google Scholar
|
|
8
|
Frank RT, Najbauer J and Aboody KS:
Concise review: stem cells as an emerging platform for antibody
therapy of cancer. Stem Cells. 28:2084–2087. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tabatabai G and Weller M: Glioblastoma
stem cells. Cell Tissue Res. 343:459–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soltanian S and Matin MM: Cancer stem
cells and cancer therapy. Tumour Biol. 32:425–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Holland EC, Celestino J, Dai C, Schaefer
L, Sawaya RE and Fuller GN: Combined activation of Ras and Akt in
neural progenitors induces glioblastoma formation in mice. Nat
Genet. 25:55–57. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alexiou GA, Vartholomatos G, Karamoutsios
A, Batistatou A, Kyritsis AP and Voulgaris S: Circulating
progenitor cells: a comparison of patients with glioblastoma or
meningioma. Acta Neurol Belg. 113:7–11. 2013. View Article : Google Scholar
|
|
13
|
Grobben B, De Deyn PP and Slegers H: Rat
C6 glioma as experimental model system for the study of
glioblastoma growth and invasion. Cell Tissue Res. 310:257–270.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goffart N, Kroonen J and Rogister B:
Glioblastoma-initiating cells: relationship with neural stem cells
and the micro-environment. Cancers (Basel). 5:1049–1071. 2013.
View Article : Google Scholar
|
|
15
|
Zhao D, Najbauer J, Garcia E, Metz MZ,
Gutova M, Glackin CA, Kim SU and Aboody KS: Neural stem cell
tropism to glioma: critical role of tumor hypoxia. Mol Cancer Res.
6:1819–1829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barth RF and Kaur B: Rat brain tumor
models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98,
BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 94:299–312. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng M and Qin G: Progenitor cell
mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit.
Prog Mol Biol Transl Sci. 111:243–264. 2012. View Article : Google Scholar
|
|
18
|
Heese O, Disko A, Zircel D, et al: Neural
stem cell migration toward gliomas in vivo. Neuro Oncol. 7:476–484.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bajeto A, Barbieri F, Dorcaratto A, et al:
Expression of CXC chemokine receptors 1–5 and their ligands in
human glioma tissues: role of CXCR4 and SDF1 in glioma cell
proliferation and migration. Neurochem Int. 49:423–432. 2006.
View Article : Google Scholar
|
|
20
|
Cheng M, Zhou J, Wu M, Boriboun C, Thorne
T, Liu T, Xiang Z, Zeng Q, Tanaka T, Tang YL, et al: CXCR4-mediated
bone marrow progenitor cell maintenance and mobilization a
modulated by c-kit activity. Circ Res. 107:1083–1093. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang R, Zhang Q, Zeh HJ III, Lotze MT and
Tang D: HMGB1 in cancer: good, bad or both? Clin Cancer Res.
19:4046–4057. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin D, Zhang Z, Gao S and Li B: The role
of chemokine receptor CXCR4 and its ligand CXCL12 in the process of
proliferation and migration of oral squamous cell carcinoma. Hua Xi
Kou Qiang Yi Xue Za Zhi. 31:8–12. 2013.(In Chinese). PubMed/NCBI
|
|
23
|
Zheng H, Ying H, Yan H, Kimmelman AC,
Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, et al: p53
and Pten control neural and glioma stem/progenitor cell renewal and
differentiation. Nature. 455:1129–1133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Greenbaum A, Hsu YM, Day RB, Schuettpelz
LG, Christopher MJ, Borgerding JN, Nagasawa T and Link DC: CXCL12
in early mesenchymal progenitors is required for hematopoietic
stem-cell maintenance. Nature. 495:227–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
